| Current Price | $71.15 | Mkt Cap | $121.4B |
|---|---|---|---|
| Open | $71.50 | P/E Ratio | 31.22 |
| Prev. Close | $71.15 | Div. (Yield) | $2.37 (3.4%) |
| Daily Range | $71.12 - $72.20 | Volume | 6,126,120 |
| 52-Wk Range | $64.62 - $104.83 | Avg. Daily Vol. | 9,359,197 |
The Company's current operations are grouped into two businesses: Retail Pharmacy and Pharmacy Benefit Management.
| Current Price | $71.15 | Mkt Cap | $121.4B |
|---|---|---|---|
| Open | $71.50 | P/E Ratio | 31.22 |
| Prev. Close | $71.15 | Div. (Yield) | $2.37 (3.4%) |
| Daily Range | $71.12 - $72.20 | Volume | 6,126,120 |
| 52-Wk Range | $64.62 - $104.83 | Avg. Daily Vol. | 9,359,197 |
The best Bull and Bear pitches based on recency and number of recommendations.
CVS Health will benefit from an aging population in the years ahead, which is why analysts expect 6% annual earnings growth in the next five years. Trading at 11 times this year's EPS forecast, CVS Health is priced at a discount. Add in the 2.4%… More
CVS is successfully commodifying and vertically integrating healthcare, that's going to be more negative for other companies than it will be positive for CVS and other industries will outperform it.So while it will probably outperform other companies… More
Read the most recent pitches from players about CVS.
Recs
FVelociraptor
(86.00)
Submitted: 1/23/2023 2:21:08 PM :
Start Price:
$85.72
NYSE:CVS Score:
-23.89
https://www.luf.org
Recs
MrPrognosticator
(45.12)
Submitted: 12/4/2021 5:34:48 PM :
Start Price:
$87.54
NYSE:CVS Score:
+12.62
CVS is successfully commodifying and vertically integrating healthcare, that's going to be more negative for other companies than it will be positive for CVS and other industries will outperform it.
So while it will probably outperform other companies in its sector it fundamentally cannot outperform the S&P500 in the long term.
Recs
TMFkodyk123
(45.69)
Submitted: 10/7/2021 7:15:03 PM :
Start Price:
$80.26
NYSE:CVS Score:
-8.79
CVS Health will benefit from an aging population in the years ahead, which is why analysts expect 6% annual earnings growth in the next five years. Trading at 11 times this year's EPS forecast, CVS Health is priced at a discount. Add in the 2.4% yield and you have all the necessary ingredients to outperform the S&P 500.
Find the members with the highest scoring picks in CVS.
MikeTheAx (< 20) Score: +190.96
The Score Leader is the player with the highest score across all their picks in CVS.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| MikeTheAx | < 20 | 3/27/2009 |
|
3M | $21.05 | +239.92% | +430.88% | +190.96 | 0 Comment | |
| stroddy | 61.29 | 5/8/2009 |
|
NS | $23.92 | +199.13% | +372.57% | +173.44 | 0 Comment | |
| Normgru | < 20 | 12/30/2008 |
|
3W | $20.86 | +243.01% | +395.31% | +152.30 | 1 Comment | |
| loudoungroup | < 20 | 6/3/2009 |
|
5Y | $22.76 | +214.40% | +364.42% | +150.01 | 0 Comment | |
| TerriEconomics | < 20 | 1/2/2009 |
|
3W | $21.33 | +235.50% | +384.31% | +148.80 | 0 Comment | |
| SilentGood | 95.73 | 10/16/2009 |
|
5Y | $28.25 | +153.25% | +295.61% | +142.36 | 0 Comment | |
| BuyTheDip | 26.34 | 10/8/2009 |
|
5Y | $26.75 | +167.45% | +303.96% | +136.51 | 0 Comment | |
| thewindowlicker | 26.32 | 12/22/2008 |
|
NS | $19.54 | +266.13% | +394.49% | +128.36 | 0 Comment | |
| dflame | < 20 | 10/28/2008 |
|
1Y | $18.55 | +285.71% | +412.63% | +126.92 | 0 Comment | |
| GuruMF3 | 69.84 | 6/27/2016 |
|
5Y | $76.57 | -6.54% | +115.72% | +122.26 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
